Skip to content

Evaluate the Hair Reduction and Hair Growth Retardation Efficacy of Onesto Serum (Roll-On)

An Intra-Body, Placebo-Controlled Clinical Study to Evaluate the Hair Reduction and Hair Growth Retardation Efficacy of Onesto Serum (Roll-On) on Underarm Using TrichoScan Analysis - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/113167
Enrollment
32
Registered
2026-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Onesto Serum: Glide the rollerball in 2 to 4 smooth, even strokes across your underarm of the Test product. Dosage Form: Roll-On Serum. Route of Application: Topical, Dura

Sponsors

Onesto Labs Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy male or female subjects aged 18 45 years 2. Presence of visible terminal hair in the selected test area 3. Willingness to comply with study procedures 4. Signed Informed Consent Form (ICF) 5. Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 6. Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 7. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1.Active skin disease or infection at the test site 2.History of hypersensitivity to cosmetic products 3.Use of hair growth inhibitors or laser hair removal in the past 3 months 4.Pregnant or lactating women 5.Participation in another clinical study within 30 days.

Design outcomes

Primary

MeasureTime frame
1. Change in hair density 2. Change in Hair Thickness 3. Change in Hair SoftnessTimepoint: At Day 0, Day 14 and Day 28

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026